The oil was full spectrum 20:1 CBD oil (20% CBD and 1%THC). At the end of the 7-month period, 80% these autistic children showed improvements in unwanted behaviors and 50% improved in their communication skills. These initial results are so promising that the team is immediately setting up a double-blind placebo trial that will complete sometime in 2019.
Jennifer is Editor in Chief for Rxleaf. She has been employed as a professional writer for over fifteen years. Jennifer graduated from the University of Guelph with an Honors Biological Science degree, majoring in the biomedical field.